UNSPSC 51173103: Ranitidine/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA301. This VA Drug Class (GA301) classifies this compound as belonging to the group HISTAMINE ANTAGONISTS.

UNSPSC 51173103 Ranitidine/sodium chloride, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code nominally describes a pharmaceutical product, but the only recent opportunities tagged to it involve chemical supplies unrelated to pharmaceutical use: liquid aluminum sulfate for wastewater treatment and medical first aid supplies for fire rescue operations. State and local governments are not procuring ranitidine or sodium chloride solutions under this code in the recent record, and the opportunities that do appear under it do not reflect the code's stated pharmaceutical scope. The City of Austin issued an IFB for liquid aluminum sulfate (alum) as a coagulant for phosphorus removal in wastewater treatment, and the City of Tampa issued an ITB for a range of medical aid supplies including first aid kits, bandages, and over-the-counter pain relievers — neither procurement involves the gastric antacid or electrolyte replacement product the code describes.

The geographic spread of tagged activity is limited to Texas and Florida based on recent postings. The City of Austin's IFB 2200 CSH1061 for liquid aluminum sulfate closed August 25, 2026, with an estimated annual volume of 179,200 gallons and local business and small business preference discounts of up to 5%, and the City of Tampa's ITB 25-P-00157 for medical aid supplies (posted April 24, 2026, with a closing date of April 9, 2025) budgeted $100,000 with set-aside provisions for small local business enterprises and underutilized minority- and women-owned businesses. This code presents a low-pursuit signal: the nominal pharmaceutical scope does not match posted opportunities, and recent activity is sparse and geographically narrow. Vendors seeking ranitidine or sodium chloride procurement opportunities should monitor alternative pharmaceutical or medical supply codes rather than rely on this classification.